Genetics Network Co-Chairs:
Anu Loukola, Ph.D.
Dr. Anu Loukola is a senior scientist and an Adjunct Professor in the Department of Public Health at the University of Helsinki, Finland. Dr. Loukola’s research is aimed at identifying novel genes and pathways associated with smoking behavior, nicotine dependence, and co-morbid neuropsychiatric disorders. She is using twin and population samples to identify genetic and epigenetic influences on smoking behavior. As a co-chair, she works with Dr. Ehringer and other members of the network to develop projects that disseminate information about the role of genetics in smoking behaviors, via Webinars, workshops at the annual meeting, paper development, and website content.
Marissa Ehringer, Ph.D.
Dr. Marissa Ehringer is an Associate Professor in the Department of Integrative Physiology and a Faculty Fellow at the Institute for Behavioral Genetics at the University of Colorado, Boulder. Dr. Ehringer's research is aimed at identifying and understanding genetic underpinnings associated with alcohol and nicotine addiction, using a combination of human statistical genetics, molecular genetics, and mouse behavioral genetic models. As co-chair, she works with Dr. Loukola and other members of the network to develop projects that disseminate information about the role of genetics in smoking behaviors, via Webinars, workshops at the annual meeting, paper development, and website content. She is also a member of the Basic Science Network, which allows her to serve as a liaison between these two groups.
Advisory Committee Members:
Andrew Bergen, Ph.D.
Dr. Andrew Bergen serves as Principal Genetic Epidemiologist at BioRealm in Culver City, CA, and as a Special Volunteer in the Genetic Epidemiology Branch at the National Cancer Institute in Shady Grove, MD. Dr. Bergen’s research is focused on the molecular genetics of tobacco use disorder and response to treatment. He works in multiple collaborations, with datasets of various designs, to investigate molecular genetic, environment, and treatment factors. He has previously served as co-Chair of the SRNT Genetics Network, and currently serves as a member of the Genetics Network, contributing to efforts to encourage and to disseminate collaborative nicotine and tobacco research.
Sean P. David, M.D., S.M., D.Phil.
Dr. David is a physician scientist with training in family medicine, public health, and pharmacogenetics. He is an Associate Professor of Medicine at Stanford University School of Medicine. He was an Institute of Medicine Anniversary Fellow (2011-2013) and is a member of the Board of US BMJ Fellows, the Truth Initiative Strategic Dialogue on Harm Reduction II. He is presently a faculty member with the Division of General Medical Disciplines, the Stanford Meta Research Innovation Center (METRICS) and Stanford Research into The Impact of Tobacco Advertising (SRITA). He led the Study of Tobacco Use in Minority Populations (STOMP) Genetics Consortium, is a co-investigator with the GWAS and Sequencing Consortium of Alcohol and Nicotine Use (GSCAN) and leads the Cochrane Review 'Genomic analyses to guide choice of treatment for smoking cessation' with Andrew Bergen and Marcus Munafo. As a member of the SRNT Global Genetics and Treatment networks and through work as recent Chair of the Program Committee of the SRNT Annual Meeting, he is active in multiple efforts to engage and inform the SRNT membership on translation of genomic knowledge to clinical research.
Jaakko Kaprio, M.D., Ph.D.
Jaakko Kaprio, M.D., Ph.D. is Professor of Genetic Epidemiology, University of Helsinki, Finland. He currently holds a five-year research professorship and is also Director of the Institute for Molecular Medicine FIMM. Among his central interests are genetic and environmental influences on smoking, nicotine dependence and smoking-related diseases. He has engaged in extensive international collaborations. He has served as co-chair of the SRNT Genetics Network and as President of the Society for Research on Nicotine and Tobacco European chapter, and has been active in tobacco-related NGOs in Finland. He is currently President of the Behavior Genetics Association.
Nancy Saccone, Ph.D.